View ValuationThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsFUJIFILM Holdings 将来の成長Future 基準チェック /06FUJIFILM Holdingsは、6.2%と3%でそれぞれ年率6.2%で利益と収益が成長すると予測される一方、EPSはgrowで6.6%年率。主要情報6.2%収益成長率6.56%EPS成長率Tech 収益成長0%収益成長率3.0%将来の株主資本利益率n/aアナリストカバレッジGood最終更新日09 Jun 2023今後の成長に関する最新情報お知らせ • Aug 07+ 1 more updateFUJIFILM Holdings Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025FUJIFILM Holdings Corporation revised consolidated earnings guidance for the fiscal year ending March 31, 2025. For the year, the company now expects revenue of JPY 3,150.0 billion, operating income of JPY 315.0 billion, income before income taxes of JPY 330.0 billion, net income attributable to company of JPY 250.0 million or JPY 207.63 per share against revenue of JPY 3,100.0 billion, operating income of JPY 300.0 billion, income before income taxes of JPY 310.0 billion, net income attributable to company of JPY 240.0 million or JPY 199.32 per share as previously forecasted.お知らせ • Nov 08Fujifilm Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024FUJIFILM Holdings Corporation provided consolidated earnings guidance for the fiscal year ending March 31, 2024. For the year, the company expects revenue of JPY 2,950,000 million, operating income of JPY 290,000 million, net income attributable to the company of JPY 225,000 million and net income attributable to the company per share of JPY 560.63.お知らせ • Feb 08+ 1 more updateFUJIFILM Holdings Corporation Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023FUJIFILM Holdings Corporation provided consolidated earnings guidance for the year ending March 31, 2023. For the year, the company expects revenue of JPY 2,800,000 million, operating income of JPY 260,000 million, net income attributable to the company of JPY 200,000 million and net income attributable to the company per share of JPY 498.64.すべての更新を表示Recent updatesお知らせ • Sep 21FUJIFILM Holdings Corporation to Report Q2, 2025 Results on Nov 07, 2024FUJIFILM Holdings Corporation announced that they will report Q2, 2025 results on Nov 07, 2024お知らせ • Aug 07+ 1 more updateFUJIFILM Holdings Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025FUJIFILM Holdings Corporation revised consolidated earnings guidance for the fiscal year ending March 31, 2025. For the year, the company now expects revenue of JPY 3,150.0 billion, operating income of JPY 315.0 billion, income before income taxes of JPY 330.0 billion, net income attributable to company of JPY 250.0 million or JPY 207.63 per share against revenue of JPY 3,100.0 billion, operating income of JPY 300.0 billion, income before income taxes of JPY 310.0 billion, net income attributable to company of JPY 240.0 million or JPY 199.32 per share as previously forecasted.お知らせ • Jun 22FUJIFILM Holdings Corporation to Report Q1, 2025 Results on Aug 07, 2024FUJIFILM Holdings Corporation announced that they will report Q1, 2025 results on Aug 07, 2024お知らせ • Apr 27FUJIFILM Holdings Corporation Introduces Transducer for On-Pump Intracardiac Echocardiography Imaging (OPIE) for Septal MyectomyFUJIFILM Healthcare Americas Corporation announced the launch of its OPIE Transducer for on-pump intracardiac echocardiography (OPIE) for septal myectomy. Early clinical users of the OPIE transducer will discuss how the technology helps to evaluate the ventricular septal thickness during septal myectomy surgery by providing real-time imaging visualization during the 104th American Association for Thoracic Surgery (AATS) meeting held April 27-30 in Toronto, ON, Canada. Traditionally, a cardiothoracic surgeon uses transesophageal echocardiography (TEE) before performing septal myectomy. Currently, TEE cannot be leveraged during cardiac bypass surgery. Instead, a surgeon views the patient's septal thickness via TEE prior to performing open-heart surgery and would trim the septum - if necessary - without real-time guidance. However, with OPIE, a thin transducer is passed into the heart during the myectomy where images of the patient's septal thick can be seen in real-time. Real-time measurements of the interventricular septal thickness are crucial during septal myectomy to avoid creating a ventricular septal defect while resecting enough myocardium. The OPIE transducer is compatible with Fujifilm's premium ultrasound system, the ARIETTA Precision. During the AATS annual meeting, Daniel G. Swistel, MD, Professor, Department of Cardiothoracic Surgery at NYU Grossman School of Medicine and Nicolas Smedira, MD, Cardiothoracic Surgeon with the Cleveland Clinic, will discuss their clinical experience using Fujifilm's ARIETTA Precision with the OPIE transducer during open heart surgery, and explain the advantages of cardiothoracic surgeons having real-time visualization to help assist with septal myectomy surgical procedures. Their joint presentation is taking place on April 27th from 6:20-6:40 pm at the Product Technology Theatre (Theatre 2). In addition to the OPIE Transducer and ARIETTA Precision Ultrasound system, Fujifilm will also demonstrate the ELUXEO Vision, an FDA-designated Breakthrough Device that provides real-time tissue oxygenation visualization for laparoscopic and endoscopic applications at AATS booth #431A. Also during the AATS annual meeting, Takeo Fujita, MD, PhD, FACS, Director, Division of Digestive Surgical Oncology, Esophageal Surgery with the National Cancer Center Hospital East, Japan, will discuss how the ELUXEO Vision helps assess tissue oxygen saturation and its correlation with indocyanine green in the gastric conduit during thoracic esophagectomy on April 29 from 9:00-9:30 am at the Tech Theater Session II. The OPIE transduer is currently available in the United States and is pending regulatory requirements in Canada.お知らせ • Mar 28FUJIFILM Holdings Corporation, Annual General Meeting, Jun 27, 2024FUJIFILM Holdings Corporation, Annual General Meeting, Jun 27, 2024. Agenda: To consider New Share-Based Remuneration Plan for Directors.お知らせ • Mar 22FUJIFILM Holdings Corporation to Report Fiscal Year 2024 Results on May 09, 2024FUJIFILM Holdings Corporation announced that they will report fiscal year 2024 results on May 09, 2024お知らせ • Dec 21FUJIFILM Holdings Corporation to Report Q3, 2024 Results on Feb 08, 2024FUJIFILM Holdings Corporation announced that they will report Q3, 2024 results on Feb 08, 2024お知らせ • Nov 08Fujifilm Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024FUJIFILM Holdings Corporation provided consolidated earnings guidance for the fiscal year ending March 31, 2024. For the year, the company expects revenue of JPY 2,950,000 million, operating income of JPY 290,000 million, net income attributable to the company of JPY 225,000 million and net income attributable to the company per share of JPY 560.63.お知らせ • Sep 22FUJIFILM Holdings Corporation to Report Q2, 2024 Results on Nov 08, 2023FUJIFILM Holdings Corporation announced that they will report Q2, 2024 results on Nov 08, 2023お知らせ • Sep 21Fujifilm North America Corporation Announces the Launch of the Instax Pal Digital Camera and Instax Mini Link 2 Smartphone Printer BundleFUJIFILM North America Corporation announced the launch of the INSTAX PAL™?digital camera and INSTAX MINI LINK™? 2 Smartphone Printer Bundle, for ages 13+. Fujifilm North America Corporation announced the launch the INSTAX PAL™? digital camera and INSTAX MINI Link™? 2 Smartphone Pr Inter Bundle, for ages 13+. FUJIFILM North America Corp. announced the launch of the INSTax PAL digital camera and INSTAX MIN I LINK™? 2 Smartphone printer, for ages 13+. FujIFILM North America Corporation, a marketing subsidiary of FUJIFILM Holdings America Corporation, consists of five operating divisions and one subsidiary company. The Imaging Division provides consumer and commercial photo products and services, including: photographic paper; digital printing equipment, along with service and support; personalised photo products; film; one-time-use cameras; and the popular INSTAX®? line of instant cameras and accessories. The Electronic Imaging Division markets consumer digital cameras, lenses, and content creation solutions, and the Graphic Communication Division supplies products and services to the graphic printing industry. The Optical Devices Division provides optical lenses for the broadcast, cinematography, closed circuit television, videography, and industrial markets, and also markets binoculars and other optical imaging solutions. The Industrial and Corporate New Business Development Division, is also pleased to introduce its new INSTAX MINI Soft Lavender instant print film pack, featuring a simple, light purple design on a 2" x 3" size INSTAX MINI photo, which allows users to write words and memorable updates on the film frame. INSTAX MINI Softavender instant film will be available in a 10-exposure pack. It can be used with the INSTAX PAL digital camera, any INSTAX MINI instant cameras and all INSTAX MINI LINK™™? Smartphone printers. bundle Pricing and Availability: The INSTAX PAL digital camera and INSTAXMINI LINK 2 Smartphone printer bundle will offer the INSTAX PAL camera (and coordinating multi-use, detachable ring) in Pistachio Green, with the INSTAX MINI LINK 2 Smartphone printer in Clay White. The bundle also includes a 10-pack of INSTAX MINI white border instant film, along with a help DIY Idea Booklet. The bundle is expected to be available in late October 2023 at a Manufacturer's Suggested Retail Price of $199.95 USD. The free, downloadable INSTAX PAL Smartphone App is also expected to be available in late September 2023.お知らせ • Aug 24Fujifilm Healthcare Americas Corporation Launches New MRI System, ECHELON Synergy with Deep Learning Reconstruction TechnologyFUJIFILM Healthcare Americas Corporation announced FDA 510(k) clearance of its new 1.5 Tesla magnetic resonance imaging (MRI) system, the ECHELON Synergy. The system employs Synergy DLR, Fujifilm's proprietary Deep Learning Reconstruction (DLR) technology powered by artificial intelligence (AI), to enhance the sharpness of images and acquire scans faster, contributing to higher throughput, image quality and patient satisfaction. A recent study conducted by NYU Grossman School of Medicine and Meta AI Research indicates that reconing MRI images with AI delivers scans four times faster than standard scans, which could expand MRI access to more patients and reduce wait times for appointments. In addition to Fujifilm's sophisticated DLR technology, ECHELON Synergy's unique AutoExam One Touch operation provides technologists with an automated workflow for brain and knee exams. AutoExam One Touch operation automatically positions the patient and starts the exam after the scan room door is closed, to speed technologists workflow and exam times for patients. Designed to enhance patient comfort, ECHELON Sy Synergy features a wide, 70 centimeter-wide bore and 62 centimeter-wide table accommodating patients up to 550 pounds. SoftSound™? gradient technology reduces acoustic noise, further enhancing the patient experience. To help reduce healthcare associated infections (HAIs), Fujifilm's exclusive Hydro AG antibacterial coating is embedded onto the system's high touch surfaces. The antibacterial coating provides a layer of added protection to suppress growth of various types of bacteria, microorganisms and mold on the surfaces, and is 99.99% effective against most common bacteria.お知らせ • Jun 24FUJIFILM Holdings Corporation to Report Q1, 2024 Results on Aug 09, 2023FUJIFILM Holdings Corporation announced that they will report Q1, 2024 results on Aug 09, 2023お知らせ • May 10FUJIFILM Holdings Corporation, Annual General Meeting, Jun 29, 2023FUJIFILM Holdings Corporation, Annual General Meeting, Jun 29, 2023.Upcoming Dividend • Mar 23Upcoming dividend of JP¥60.00 per share at 1.8% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 30 June 2023. Payout ratio is a comfortable 22% but the company is not cash flow positive. Trailing yield: 1.8%. Lower than top quartile of Mexican dividend payers (5.9%). Higher than average of industry peers (1.0%).Reported Earnings • Feb 09Third quarter 2023 earnings released: EPS: JP¥146 (vs JP¥152 in 3Q 2022)Third quarter 2023 results: EPS: JP¥146 (down from JP¥152 in 3Q 2022). Revenue: JP¥744.3b (up 14% from 3Q 2022). Net income: JP¥58.6b (down 3.7% from 3Q 2022). Profit margin: 7.9% (down from 9.3% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Global Tech industry.お知らせ • Feb 08+ 1 more updateFUJIFILM Holdings Corporation Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023FUJIFILM Holdings Corporation provided consolidated earnings guidance for the year ending March 31, 2023. For the year, the company expects revenue of JPY 2,800,000 million, operating income of JPY 260,000 million, net income attributable to the company of JPY 200,000 million and net income attributable to the company per share of JPY 498.64.お知らせ • Jan 05Fujifilm Announces Addition of Splatoon™ 3 and Other Unique Features in the Updated Instax Mini Link® for Nintendo Switch™ Smartphone AppFUJIFILM Corporation in collaboration with Nintendo Co. Ltd. continues to revolutionize how gamers can share the fun of their game play, with the significant addition of Splatoon 3 characters as well as a variety of unique features in the FUJIFILM INSTAX MINI LINK ® for Nintendo Switch App[1]. With the App, users can share their favorite character moments with fellow gamers digitally or by printing a custom, one-of-a-kind INSTAX photo from their FUJIFILM INSTAX MINI LINK series Smartphone Printer. The free, downloadable INSTAX MINI LINK for Nintendo Switch App allows filters and frames to be added to screenshots taken using the Nintendo Switch system’s capture function, which can be transmitted to your Smartphone and then printed onto FUJIFILM INSTAX instant photos via the INSTAX MINI LINK Series of Smartphone Printers. A simple QR Code scan of the Nintendo Switch game screen using the INSTAX MINI LINK for Nintendo Switch App on your Smartphone allows the image to be printed with a variety of frames and stickers based on characters from Nintendo Switch games including Animal Crossing™: New Horizons, Super Mario™, New Pokémon Snap™, and now, Splatoon 3. Within the updated App, the INSTAXAiR feature allows users of any INSTAX MINI LINK 2 printer to add a variety of graphics, including Splatoon 3 characters, to their Smartphone photos, as well as the other standard effects of INSTAXAiR, including bubbles, petals, neon, spray paint, or a glitter look by simply holding the printer, pressing the feature button on top, and aiming the side LED to draw in the air. What is drawn in the air will then appear on the print preview in-App, and once the user is happy with the look, the graphics will appear on the print itself when printed with the INSTAX MINI LINK 2 Smartphone printer. Users of the INSTAXAiR feature can even record a video of the drawing and share the moment as a printable QR code that appears on the printed INSTAX photo. The QR code can be scanned with your Smartphone to view the video, download it, or share it on social media.お知らせ • Dec 21FUJIFILM Holdings Corporation to Report Q3, 2023 Results on Feb 08, 2023FUJIFILM Holdings Corporation announced that they will report Q3, 2023 results on Feb 08, 2023お知らせ • Nov 22FUJIFILM Holdings Corporation Unveils Latest Version of the Synapse 7x Enterprise Imaging Platform at the 2022 Radiological Society of North America Annual MeetingFUJIFILM Healthcare Americas Corporation, released Synapse 7.2 - it’s latest version of Synapse 7x –the company’s next-generation enterprise picture archiving and communication system. Synapse 7x unites radiology, mammography, cardiology and enterprise imaging on an all-encompassing, server-side rendering, cloud deployable, diagnostic PACS viewer. Version 7.2 delivers more than 80 new workflow features and advanced toolsets to enhance the efficiency of clinical radiology and cardiology users, as well as IT professionals, and will be exhibited in booth #1929 at the 2022 Radiological Society of North America annual meeting held November 27 – December 1 at McCormick Place in Chicago. Synapse 7x version 7.2 delivers a host of workflow enhancements to support radiology, cardiology, and IT staff, in particular: Series picker user preferences to move, pop-out and hide for efficient viewing and accessing desired image sets. Mammography updates to synchronize scrolling and stacking as well as “image not viewed” alerts that assist with more efficient digital breast tomosynthesis reading Cardiology protocol panel placement and diagramming improvements across non-invasive and cardiac cath for more productive cardiology reporting, Continued artificial intelligence development of third-party algorithm and API support to provide comprehensive AI packages.Board Change • Nov 16Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 independent directors. 7 non-independent directors. Independent Outside Director Tsuyoshi Nagano was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.Reported Earnings • Nov 11Second quarter 2023 earnings released: EPS: JP¥134 (vs JP¥97.33 in 2Q 2022)Second quarter 2023 results: EPS: JP¥134 (up from JP¥97.33 in 2Q 2022). Revenue: JP¥724.1b (up 16% from 2Q 2022). Net income: JP¥53.8b (up 38% from 2Q 2022). Profit margin: 7.4% (up from 6.3% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Global Tech industry.お知らせ • Nov 11+ 1 more updateFujifilm Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023; Announces second quarter dividend for the year ended September 30, 2022, Payable on December 2 ,2022FUJIFILM Holdings Corporation provided dividend guidance for the fiscal year ending March 31, 2023. For the year end, the company expects to pay a dividend of JPY 60.00 per share against JPY 55 per share paid a year ago.The company announced second quarter dividend of JPY 60 per share for the year ended March 31, 2022 compared to JPY 55 per share paid a year ago. Projected date of the beginning of cash dividend is December 2,2022.お知らせ • Nov 03Fujifilm Introduces the New Fujinon Xf30mmf2.8 Macro Lens with A Minimum Focusing Distance of 3.94 In. (10Cm)FUJIFILM North America Corporation announced the new FUJINON XF30mmF2.8 R LM WR lens (XF30mmF2.8 Macro), a standard prime lens with the focal length of 30mm (equivalent to 46mm in the 35mm film format). XF30mmF2.8 Macro is designed for macro photography and features a 1:1 magnification ratio with a minimum focusing distance of just 3.94 in.1 (10cm) from the sensor. Enabling macro photography in a variety of applications: XF30mmF2.8 Macro’s design consists of 11 elements in 9 groups (including 3 aspherical elements and 2 ED elements), controls various forms of aberration (including chromatic aberration, spherical aberration and field curvature) to deliver advanced image-resolving performance. The standard 30mm focal length (equivalent to 46mm in the 35mm film format), which is close to the human field-of-view, also makes it an ideal choice across portraiture and wedding photography, and other genres where a lens with a natural field-of- view is desired. Use of a linear motor and a compact lightweight design provides fast and accurate autofocus: XF30mmF2.8 Macro lens uses the Inner Focus system, where the lens group is driven by a linear motor to achieve accurate focus in as fast as 0.02 seconds2. The focusing operation is quiet and smooth even for close-up photography, which traditionally has required large movement of focusing elements. The linear motor’s advanced resolution capability ensures focusing accuracy even in macro photography with a very shallow depth-of-field. The design and engineering of XF30mmF2.8 Macro prioritizes a natural and compact form factor; the result is a lightweight lens weighing 6.88 ounces (195g) and measuring 2.74 in. (69.5mm) in length with a filter thread size of 43mm. Dust- and weather-resistant design capable of operating at low temperatures for advanced practical usability: The lens barrel is sealed in 9 places to ensure consistent operation in temperatures as low as 14°F (-10°C), and dust- and weather-resistance. Pricing and Availability: XF30mmF2.8 Macro is expected to be available in late November 2022, at a manufacturer’s suggested retail price of $599.95 (CAD 809.99). This refers to distance from the sensor surface to the subject. The distance from the front lens element to the subject is .47 in. (1.2cm). Using applicable CIPA Guideline measurement methods, when mounted on the FUJIFILM X-T4 mirrorless digital camera with Phase Detection AF activated and using High Performance Mode.お知らせ • Sep 24FUJIFILM Holdings Corporation to Report Q2, 2023 Results on Nov 10, 2022FUJIFILM Holdings Corporation announced that they will report Q2, 2023 results on Nov 10, 2022Upcoming Dividend • Sep 22Upcoming dividend of JP¥60.00 per shareEligible shareholders must have bought the stock before 29 September 2022. Payment date: 02 December 2022. Payout ratio is a comfortable 23% and the cash payout ratio is 91%. Trailing yield: 1.8%. Lower than top quartile of Mexican dividend payers (6.3%). Higher than average of industry peers (1.1%).Reported Earnings • Aug 11First quarter 2023 earnings released: EPS: JP¥103 (vs JP¥143 in 1Q 2022)First quarter 2023 results: EPS: JP¥103 (down from JP¥143 in 1Q 2022). Revenue: JP¥625.9b (up 7.4% from 1Q 2022). Net income: JP¥41.4b (down 28% from 1Q 2022). Profit margin: 6.6% (down from 9.8% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 3.9%, compared to a 5.2% growth forecast for the industry in Mexico.Board Change • Jul 18Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 independent directors. 7 non-independent directors. Independent Outside Director Tsuyoshi Nagano was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.お知らせ • Jul 07Fujifilm Launches Fujifilm Projector Z6000FUJIFILM Corporation announces it will launch “FUJIFILM PROJECTOR Z6000” in late July 2022. The new model joins the lineup of the Z Series of ultra-short-throw projectors, equipped with the industry’s only1 “folded two-axial rotatable lens.” FP-Z6000 offers a bright 6,000 lumens image projection capability and class-leading2 compact (460mm x 510mm x 162.5mm3) and lightweight design. By simply rotating “folded two-axial rotatable lens,” it is able to throw images at various directions. FP-Z6000 is also free from space constraints to accommodate highly immersive spatial designs, due to its ability to project large images from a close-up distance and to reposition them within an extensive vertical and horizontal range. In recent years, applications for projectors have been increasingly expanding into spatial design at commercial facilities, museums, and art galleries. Fujifilm entered into the projector market with the launch of the Z Series of projectors equipped with the world’s first “folded two-axial rotatable lens” in 2019. The “FUJIFILM PROJECTOR Z8000” (FP-Z8000) that the company subsequently introduced in 2021 provides bright image projection and excellent color reproduction. Users can place FP-Z8000 in inconspicuous places, drawing on the ability of the “folded two-axial rotatable lens” to project images toward various directions as well as the ability to throw massive images from a close-up distance. Since FP-Z8000 is capable of creating immersive spaces without blocking the beholders’ line of sight, its adoption in museums or immersive digital art exhibitions has been spreading. With the launch of FP-Z6000, Fujifilm adds a high-brightness model to the Z Series lineup. The company aims to expand the attraction of the series by further increasing the customers’ options. Featuring a “folded two-axial rotatable lens” for spatial presentation as intended by designer “Folded two-axial rotatable lens” can be tilted 90 degrees from the lens mount axis and rotated 360 degrees on the lens axis. The ability to throw images in various directions allows users to project images onto not only walls and screens but also ceilings and floors with ease. It can also create immersive space by hiding the main unit and exposing only lens section. Projecting massive 100-inch images from a close-up distance of 72cm The ultra-short throw lens with the TR value of 0.34 projects dynamic 100-inch images from a close-up distance of 72cm. This significantly reduces dead space between the projector and the projection surface, allowing maximum use of space. Class-leading2Wide Lens-Shift Range4 capable of 70% vertically and 35% horizontally. The use of a large-diameter aspherical lens element delivers the class-leading Lens-Shift function of up to 70% vertically and 35% horizontally. The function makes it easy to shift the position of projected images across a wide range without having to change the location of the main unit or direction of the lens. Furthermore, its 1.1x optical zoom capability means the size of projected images can be adjusted easily. This optical zoom capability can be combined with the Lens Shift function to enable efficient image adjustments. FP-Z6000 adopts the “Two-Group Focusing Mechanism,” with which the projector can independently adjust the focus of the central and peripheral parts of an image. Even when users shift the position of projected images with the Lens-Shift function, the Two-Group Focusing Mechanism allows for the projector to adjust its focal placement and offer images focused from their center to periphery.お知らせ • Jun 22FUJIFILM Holdings Corporation to Report Q1, 2023 Results on Aug 10, 2022FUJIFILM Holdings Corporation announced that they will report Q1, 2023 results on Aug 10, 2022お知らせ • Jun 09FUJIFILM Holdings Corporation (TSE:4901) agreed to acquire Unigraphica Aktiengesellschaft.FUJIFILM Holdings Corporation (TSE:4901) agreed to acquire Unigraphica Aktiengesellschaft on June 8, 2022. The company will become a wholly owned subsidiary of Fujifilm and will be named FUJIFILM UNIGRAPHICA AG from July 1st, following the closure of the deal which is expected to take place later this month.お知らせ • Jun 01FUJIFILM Corporation Begins U.S. Clinical Phase 2a Study of FF-10832 in Combination with KEYTRUDA for Patients with Advanced Solid TumorsFUJIFILM Corporation announced that it has begun implementation of a phase 2a study in the U.S. to evaluate safety, tolerability, and preliminary efficacy of FF-10832, a liposomal drug candidate, in combination therapy with Merck & Co. Inc., Rahway, N.J., U.S.A.’s anti-PD-1 therapy KEYTRUDA® (pembrolizumab) for patients with advanced solid tumors. FF-10832 is a liposomal formulation which encapsulates gemcitabine, an approved anti-cancer agent indicated for the treatment of a variety of solid tumors. The primary focus of the trial is to establish the safety and tolerability of FF-10832 in combination with KEYTRUDA in patients with advanced solid tumors, and evaluate its preliminary efficacy in non-small cell lung cancer (NSCLC) and urothelial cancer (UC) patients who have progressed after standard therapy, including immune checkpoint inhibitor therapy. This trial will enroll up to 100 patients in two indications (UC and NSCLC) into one of two treatment arms (monotherapy or in combination with KEYTRUDA). Fujifilm has completed the phase 1 dose escalation of FF-10832 monotherapy, and is currently conducting an expansion phase. FF-10832 is administered as an intravenous infusion. It consists of liposomes, artificially constructed lipid vesicles that resemble biological membranes in composition and physical properties, encapsulating gemcitabine. Encapsulating a therapeutic agent in liposomes is believed to enhance pharmacological efficacy of that agent by prolonging its circulation and improving delivery of it specifically at the tumor site. An exploratory endpoint of the clinical phase 2a study is to determine whether encapsulating gemcitabine in liposomes enhances pharmacological efficacy. Preclinical studies have demonstrated that the combination of FF-10832 and immune checkpoint inhibitors impact CD8-positive T cells and may lead to longer survival compared to monotherapy. KEYTRUDA is an anti-PD-1 immune checkpoint inhibitor therapy.Board Change • May 31Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 7 non-independent directors. Independent Outside Director Makiko Eda was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.業績と収益の成長予測BMV:4901 N - アナリストの将来予測と過去の財務データ ( )JPY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/20263,138,673272,776176,861428,79493/31/20253,000,609241,027133,468395,040143/31/20242,877,946222,214107,738384,932143/31/20232,859,041219,422-113,020210,452N/A12/31/20222,759,131207,762-101,045173,685N/A9/30/20222,670,570210,055-5,693230,798N/A6/30/20222,568,980195,22248,475243,220N/A3/31/20222,525,773211,180158,027323,934N/A12/31/20212,479,987211,796186,799341,931N/A9/30/20212,400,264209,853231,280374,120N/A6/30/20212,318,902211,011282,707415,872N/A3/31/20212,192,519181,205295,254420,861N/A12/31/20202,160,178130,818267,575385,678N/A9/30/20202,180,396131,448176,907292,673N/A6/30/20202,236,085137,826133,422247,682N/A3/31/20202,315,141124,987145,943255,667N/A12/31/20192,360,070157,712160,040268,180N/A9/30/20192,390,880133,757219,741321,624N/A6/30/20192,401,923124,444178,016270,761N/A3/31/20192,431,489138,106160,323249,343N/A12/31/20182,423,499117,236167,438249,033N/A9/30/20182,418,170135,289154,255235,451N/A6/30/20182,426,769125,216171,266254,764N/A3/31/20182,433,365140,694179,568261,152N/A12/31/20172,439,584177,278164,246251,175N/A9/30/20172,396,484168,021172,398259,696N/A6/30/20172,347,806163,240187,181277,348N/A3/31/20172,322,163131,506191,654288,619N/A12/31/20162,327,702114,874N/A272,021N/A9/30/20162,358,394106,256N/A266,544N/A6/30/20162,419,552105,707N/A259,552N/A3/31/20162,460,383116,402N/A223,479N/A12/31/20152,487,890102,024N/A229,300N/A9/30/20152,507,338117,007N/A232,998N/A6/30/20152,493,947119,875N/A234,525N/A3/31/20152,463,387110,940N/A267,778N/A12/31/20142,444,14698,247N/A292,484N/A9/30/20142,415,47278,556N/A299,359N/A6/30/20142,405,46970,436N/A306,748N/A3/31/20142,418,09571,558N/A296,589N/A12/31/20132,362,75684,492N/A270,304N/A9/30/20132,312,20871,838N/A246,804N/A6/30/20132,249,94263,293N/A224,320N/A3/31/20132,199,54050,847N/A202,099N/A12/31/20122,187,95248,910N/A184,964N/A9/30/20122,173,47139,334N/A159,587N/A6/30/20122,183,49731,749N/A153,885N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 4901 Nの予測収益成長率 (年間6.2% ) は 貯蓄率 ( 7.6% ) を下回っています。収益対市場: 4901 Nの収益 ( 6.2% ) MX市場 ( 8.5% ) よりも低い成長が予測されています。高成長収益: 4901 Nの収益は増加すると予測されていますが、大幅には増加しません。収益対市場: 4901 Nの収益 ( 3% ) MX市場 ( 6.2% ) よりも低い成長が予測されています。高い収益成長: 4901 Nの収益 ( 3% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 4901 Nの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YTech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2023/06/12 16:04終値2023/03/16 00:00収益2023/03/31年間収益2023/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋FUJIFILM Holdings Corporation 14 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。25 アナリスト機関Masahiro NakanomyoBarclaysKei TakeuchiBofA Global ResearchMasahiro ShibanoCitigroup Inc22 その他のアナリストを表示
お知らせ • Aug 07+ 1 more updateFUJIFILM Holdings Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025FUJIFILM Holdings Corporation revised consolidated earnings guidance for the fiscal year ending March 31, 2025. For the year, the company now expects revenue of JPY 3,150.0 billion, operating income of JPY 315.0 billion, income before income taxes of JPY 330.0 billion, net income attributable to company of JPY 250.0 million or JPY 207.63 per share against revenue of JPY 3,100.0 billion, operating income of JPY 300.0 billion, income before income taxes of JPY 310.0 billion, net income attributable to company of JPY 240.0 million or JPY 199.32 per share as previously forecasted.
お知らせ • Nov 08Fujifilm Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024FUJIFILM Holdings Corporation provided consolidated earnings guidance for the fiscal year ending March 31, 2024. For the year, the company expects revenue of JPY 2,950,000 million, operating income of JPY 290,000 million, net income attributable to the company of JPY 225,000 million and net income attributable to the company per share of JPY 560.63.
お知らせ • Feb 08+ 1 more updateFUJIFILM Holdings Corporation Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023FUJIFILM Holdings Corporation provided consolidated earnings guidance for the year ending March 31, 2023. For the year, the company expects revenue of JPY 2,800,000 million, operating income of JPY 260,000 million, net income attributable to the company of JPY 200,000 million and net income attributable to the company per share of JPY 498.64.
お知らせ • Sep 21FUJIFILM Holdings Corporation to Report Q2, 2025 Results on Nov 07, 2024FUJIFILM Holdings Corporation announced that they will report Q2, 2025 results on Nov 07, 2024
お知らせ • Aug 07+ 1 more updateFUJIFILM Holdings Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025FUJIFILM Holdings Corporation revised consolidated earnings guidance for the fiscal year ending March 31, 2025. For the year, the company now expects revenue of JPY 3,150.0 billion, operating income of JPY 315.0 billion, income before income taxes of JPY 330.0 billion, net income attributable to company of JPY 250.0 million or JPY 207.63 per share against revenue of JPY 3,100.0 billion, operating income of JPY 300.0 billion, income before income taxes of JPY 310.0 billion, net income attributable to company of JPY 240.0 million or JPY 199.32 per share as previously forecasted.
お知らせ • Jun 22FUJIFILM Holdings Corporation to Report Q1, 2025 Results on Aug 07, 2024FUJIFILM Holdings Corporation announced that they will report Q1, 2025 results on Aug 07, 2024
お知らせ • Apr 27FUJIFILM Holdings Corporation Introduces Transducer for On-Pump Intracardiac Echocardiography Imaging (OPIE) for Septal MyectomyFUJIFILM Healthcare Americas Corporation announced the launch of its OPIE Transducer for on-pump intracardiac echocardiography (OPIE) for septal myectomy. Early clinical users of the OPIE transducer will discuss how the technology helps to evaluate the ventricular septal thickness during septal myectomy surgery by providing real-time imaging visualization during the 104th American Association for Thoracic Surgery (AATS) meeting held April 27-30 in Toronto, ON, Canada. Traditionally, a cardiothoracic surgeon uses transesophageal echocardiography (TEE) before performing septal myectomy. Currently, TEE cannot be leveraged during cardiac bypass surgery. Instead, a surgeon views the patient's septal thickness via TEE prior to performing open-heart surgery and would trim the septum - if necessary - without real-time guidance. However, with OPIE, a thin transducer is passed into the heart during the myectomy where images of the patient's septal thick can be seen in real-time. Real-time measurements of the interventricular septal thickness are crucial during septal myectomy to avoid creating a ventricular septal defect while resecting enough myocardium. The OPIE transducer is compatible with Fujifilm's premium ultrasound system, the ARIETTA Precision. During the AATS annual meeting, Daniel G. Swistel, MD, Professor, Department of Cardiothoracic Surgery at NYU Grossman School of Medicine and Nicolas Smedira, MD, Cardiothoracic Surgeon with the Cleveland Clinic, will discuss their clinical experience using Fujifilm's ARIETTA Precision with the OPIE transducer during open heart surgery, and explain the advantages of cardiothoracic surgeons having real-time visualization to help assist with septal myectomy surgical procedures. Their joint presentation is taking place on April 27th from 6:20-6:40 pm at the Product Technology Theatre (Theatre 2). In addition to the OPIE Transducer and ARIETTA Precision Ultrasound system, Fujifilm will also demonstrate the ELUXEO Vision, an FDA-designated Breakthrough Device that provides real-time tissue oxygenation visualization for laparoscopic and endoscopic applications at AATS booth #431A. Also during the AATS annual meeting, Takeo Fujita, MD, PhD, FACS, Director, Division of Digestive Surgical Oncology, Esophageal Surgery with the National Cancer Center Hospital East, Japan, will discuss how the ELUXEO Vision helps assess tissue oxygen saturation and its correlation with indocyanine green in the gastric conduit during thoracic esophagectomy on April 29 from 9:00-9:30 am at the Tech Theater Session II. The OPIE transduer is currently available in the United States and is pending regulatory requirements in Canada.
お知らせ • Mar 28FUJIFILM Holdings Corporation, Annual General Meeting, Jun 27, 2024FUJIFILM Holdings Corporation, Annual General Meeting, Jun 27, 2024. Agenda: To consider New Share-Based Remuneration Plan for Directors.
お知らせ • Mar 22FUJIFILM Holdings Corporation to Report Fiscal Year 2024 Results on May 09, 2024FUJIFILM Holdings Corporation announced that they will report fiscal year 2024 results on May 09, 2024
お知らせ • Dec 21FUJIFILM Holdings Corporation to Report Q3, 2024 Results on Feb 08, 2024FUJIFILM Holdings Corporation announced that they will report Q3, 2024 results on Feb 08, 2024
お知らせ • Nov 08Fujifilm Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024FUJIFILM Holdings Corporation provided consolidated earnings guidance for the fiscal year ending March 31, 2024. For the year, the company expects revenue of JPY 2,950,000 million, operating income of JPY 290,000 million, net income attributable to the company of JPY 225,000 million and net income attributable to the company per share of JPY 560.63.
お知らせ • Sep 22FUJIFILM Holdings Corporation to Report Q2, 2024 Results on Nov 08, 2023FUJIFILM Holdings Corporation announced that they will report Q2, 2024 results on Nov 08, 2023
お知らせ • Sep 21Fujifilm North America Corporation Announces the Launch of the Instax Pal Digital Camera and Instax Mini Link 2 Smartphone Printer BundleFUJIFILM North America Corporation announced the launch of the INSTAX PAL™?digital camera and INSTAX MINI LINK™? 2 Smartphone Printer Bundle, for ages 13+. Fujifilm North America Corporation announced the launch the INSTAX PAL™? digital camera and INSTAX MINI Link™? 2 Smartphone Pr Inter Bundle, for ages 13+. FUJIFILM North America Corp. announced the launch of the INSTax PAL digital camera and INSTAX MIN I LINK™? 2 Smartphone printer, for ages 13+. FujIFILM North America Corporation, a marketing subsidiary of FUJIFILM Holdings America Corporation, consists of five operating divisions and one subsidiary company. The Imaging Division provides consumer and commercial photo products and services, including: photographic paper; digital printing equipment, along with service and support; personalised photo products; film; one-time-use cameras; and the popular INSTAX®? line of instant cameras and accessories. The Electronic Imaging Division markets consumer digital cameras, lenses, and content creation solutions, and the Graphic Communication Division supplies products and services to the graphic printing industry. The Optical Devices Division provides optical lenses for the broadcast, cinematography, closed circuit television, videography, and industrial markets, and also markets binoculars and other optical imaging solutions. The Industrial and Corporate New Business Development Division, is also pleased to introduce its new INSTAX MINI Soft Lavender instant print film pack, featuring a simple, light purple design on a 2" x 3" size INSTAX MINI photo, which allows users to write words and memorable updates on the film frame. INSTAX MINI Softavender instant film will be available in a 10-exposure pack. It can be used with the INSTAX PAL digital camera, any INSTAX MINI instant cameras and all INSTAX MINI LINK™™? Smartphone printers. bundle Pricing and Availability: The INSTAX PAL digital camera and INSTAXMINI LINK 2 Smartphone printer bundle will offer the INSTAX PAL camera (and coordinating multi-use, detachable ring) in Pistachio Green, with the INSTAX MINI LINK 2 Smartphone printer in Clay White. The bundle also includes a 10-pack of INSTAX MINI white border instant film, along with a help DIY Idea Booklet. The bundle is expected to be available in late October 2023 at a Manufacturer's Suggested Retail Price of $199.95 USD. The free, downloadable INSTAX PAL Smartphone App is also expected to be available in late September 2023.
お知らせ • Aug 24Fujifilm Healthcare Americas Corporation Launches New MRI System, ECHELON Synergy with Deep Learning Reconstruction TechnologyFUJIFILM Healthcare Americas Corporation announced FDA 510(k) clearance of its new 1.5 Tesla magnetic resonance imaging (MRI) system, the ECHELON Synergy. The system employs Synergy DLR, Fujifilm's proprietary Deep Learning Reconstruction (DLR) technology powered by artificial intelligence (AI), to enhance the sharpness of images and acquire scans faster, contributing to higher throughput, image quality and patient satisfaction. A recent study conducted by NYU Grossman School of Medicine and Meta AI Research indicates that reconing MRI images with AI delivers scans four times faster than standard scans, which could expand MRI access to more patients and reduce wait times for appointments. In addition to Fujifilm's sophisticated DLR technology, ECHELON Synergy's unique AutoExam One Touch operation provides technologists with an automated workflow for brain and knee exams. AutoExam One Touch operation automatically positions the patient and starts the exam after the scan room door is closed, to speed technologists workflow and exam times for patients. Designed to enhance patient comfort, ECHELON Sy Synergy features a wide, 70 centimeter-wide bore and 62 centimeter-wide table accommodating patients up to 550 pounds. SoftSound™? gradient technology reduces acoustic noise, further enhancing the patient experience. To help reduce healthcare associated infections (HAIs), Fujifilm's exclusive Hydro AG antibacterial coating is embedded onto the system's high touch surfaces. The antibacterial coating provides a layer of added protection to suppress growth of various types of bacteria, microorganisms and mold on the surfaces, and is 99.99% effective against most common bacteria.
お知らせ • Jun 24FUJIFILM Holdings Corporation to Report Q1, 2024 Results on Aug 09, 2023FUJIFILM Holdings Corporation announced that they will report Q1, 2024 results on Aug 09, 2023
お知らせ • May 10FUJIFILM Holdings Corporation, Annual General Meeting, Jun 29, 2023FUJIFILM Holdings Corporation, Annual General Meeting, Jun 29, 2023.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥60.00 per share at 1.8% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 30 June 2023. Payout ratio is a comfortable 22% but the company is not cash flow positive. Trailing yield: 1.8%. Lower than top quartile of Mexican dividend payers (5.9%). Higher than average of industry peers (1.0%).
Reported Earnings • Feb 09Third quarter 2023 earnings released: EPS: JP¥146 (vs JP¥152 in 3Q 2022)Third quarter 2023 results: EPS: JP¥146 (down from JP¥152 in 3Q 2022). Revenue: JP¥744.3b (up 14% from 3Q 2022). Net income: JP¥58.6b (down 3.7% from 3Q 2022). Profit margin: 7.9% (down from 9.3% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Global Tech industry.
お知らせ • Feb 08+ 1 more updateFUJIFILM Holdings Corporation Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023FUJIFILM Holdings Corporation provided consolidated earnings guidance for the year ending March 31, 2023. For the year, the company expects revenue of JPY 2,800,000 million, operating income of JPY 260,000 million, net income attributable to the company of JPY 200,000 million and net income attributable to the company per share of JPY 498.64.
お知らせ • Jan 05Fujifilm Announces Addition of Splatoon™ 3 and Other Unique Features in the Updated Instax Mini Link® for Nintendo Switch™ Smartphone AppFUJIFILM Corporation in collaboration with Nintendo Co. Ltd. continues to revolutionize how gamers can share the fun of their game play, with the significant addition of Splatoon 3 characters as well as a variety of unique features in the FUJIFILM INSTAX MINI LINK ® for Nintendo Switch App[1]. With the App, users can share their favorite character moments with fellow gamers digitally or by printing a custom, one-of-a-kind INSTAX photo from their FUJIFILM INSTAX MINI LINK series Smartphone Printer. The free, downloadable INSTAX MINI LINK for Nintendo Switch App allows filters and frames to be added to screenshots taken using the Nintendo Switch system’s capture function, which can be transmitted to your Smartphone and then printed onto FUJIFILM INSTAX instant photos via the INSTAX MINI LINK Series of Smartphone Printers. A simple QR Code scan of the Nintendo Switch game screen using the INSTAX MINI LINK for Nintendo Switch App on your Smartphone allows the image to be printed with a variety of frames and stickers based on characters from Nintendo Switch games including Animal Crossing™: New Horizons, Super Mario™, New Pokémon Snap™, and now, Splatoon 3. Within the updated App, the INSTAXAiR feature allows users of any INSTAX MINI LINK 2 printer to add a variety of graphics, including Splatoon 3 characters, to their Smartphone photos, as well as the other standard effects of INSTAXAiR, including bubbles, petals, neon, spray paint, or a glitter look by simply holding the printer, pressing the feature button on top, and aiming the side LED to draw in the air. What is drawn in the air will then appear on the print preview in-App, and once the user is happy with the look, the graphics will appear on the print itself when printed with the INSTAX MINI LINK 2 Smartphone printer. Users of the INSTAXAiR feature can even record a video of the drawing and share the moment as a printable QR code that appears on the printed INSTAX photo. The QR code can be scanned with your Smartphone to view the video, download it, or share it on social media.
お知らせ • Dec 21FUJIFILM Holdings Corporation to Report Q3, 2023 Results on Feb 08, 2023FUJIFILM Holdings Corporation announced that they will report Q3, 2023 results on Feb 08, 2023
お知らせ • Nov 22FUJIFILM Holdings Corporation Unveils Latest Version of the Synapse 7x Enterprise Imaging Platform at the 2022 Radiological Society of North America Annual MeetingFUJIFILM Healthcare Americas Corporation, released Synapse 7.2 - it’s latest version of Synapse 7x –the company’s next-generation enterprise picture archiving and communication system. Synapse 7x unites radiology, mammography, cardiology and enterprise imaging on an all-encompassing, server-side rendering, cloud deployable, diagnostic PACS viewer. Version 7.2 delivers more than 80 new workflow features and advanced toolsets to enhance the efficiency of clinical radiology and cardiology users, as well as IT professionals, and will be exhibited in booth #1929 at the 2022 Radiological Society of North America annual meeting held November 27 – December 1 at McCormick Place in Chicago. Synapse 7x version 7.2 delivers a host of workflow enhancements to support radiology, cardiology, and IT staff, in particular: Series picker user preferences to move, pop-out and hide for efficient viewing and accessing desired image sets. Mammography updates to synchronize scrolling and stacking as well as “image not viewed” alerts that assist with more efficient digital breast tomosynthesis reading Cardiology protocol panel placement and diagramming improvements across non-invasive and cardiac cath for more productive cardiology reporting, Continued artificial intelligence development of third-party algorithm and API support to provide comprehensive AI packages.
Board Change • Nov 16Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 independent directors. 7 non-independent directors. Independent Outside Director Tsuyoshi Nagano was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
Reported Earnings • Nov 11Second quarter 2023 earnings released: EPS: JP¥134 (vs JP¥97.33 in 2Q 2022)Second quarter 2023 results: EPS: JP¥134 (up from JP¥97.33 in 2Q 2022). Revenue: JP¥724.1b (up 16% from 2Q 2022). Net income: JP¥53.8b (up 38% from 2Q 2022). Profit margin: 7.4% (up from 6.3% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Global Tech industry.
お知らせ • Nov 11+ 1 more updateFujifilm Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023; Announces second quarter dividend for the year ended September 30, 2022, Payable on December 2 ,2022FUJIFILM Holdings Corporation provided dividend guidance for the fiscal year ending March 31, 2023. For the year end, the company expects to pay a dividend of JPY 60.00 per share against JPY 55 per share paid a year ago.The company announced second quarter dividend of JPY 60 per share for the year ended March 31, 2022 compared to JPY 55 per share paid a year ago. Projected date of the beginning of cash dividend is December 2,2022.
お知らせ • Nov 03Fujifilm Introduces the New Fujinon Xf30mmf2.8 Macro Lens with A Minimum Focusing Distance of 3.94 In. (10Cm)FUJIFILM North America Corporation announced the new FUJINON XF30mmF2.8 R LM WR lens (XF30mmF2.8 Macro), a standard prime lens with the focal length of 30mm (equivalent to 46mm in the 35mm film format). XF30mmF2.8 Macro is designed for macro photography and features a 1:1 magnification ratio with a minimum focusing distance of just 3.94 in.1 (10cm) from the sensor. Enabling macro photography in a variety of applications: XF30mmF2.8 Macro’s design consists of 11 elements in 9 groups (including 3 aspherical elements and 2 ED elements), controls various forms of aberration (including chromatic aberration, spherical aberration and field curvature) to deliver advanced image-resolving performance. The standard 30mm focal length (equivalent to 46mm in the 35mm film format), which is close to the human field-of-view, also makes it an ideal choice across portraiture and wedding photography, and other genres where a lens with a natural field-of- view is desired. Use of a linear motor and a compact lightweight design provides fast and accurate autofocus: XF30mmF2.8 Macro lens uses the Inner Focus system, where the lens group is driven by a linear motor to achieve accurate focus in as fast as 0.02 seconds2. The focusing operation is quiet and smooth even for close-up photography, which traditionally has required large movement of focusing elements. The linear motor’s advanced resolution capability ensures focusing accuracy even in macro photography with a very shallow depth-of-field. The design and engineering of XF30mmF2.8 Macro prioritizes a natural and compact form factor; the result is a lightweight lens weighing 6.88 ounces (195g) and measuring 2.74 in. (69.5mm) in length with a filter thread size of 43mm. Dust- and weather-resistant design capable of operating at low temperatures for advanced practical usability: The lens barrel is sealed in 9 places to ensure consistent operation in temperatures as low as 14°F (-10°C), and dust- and weather-resistance. Pricing and Availability: XF30mmF2.8 Macro is expected to be available in late November 2022, at a manufacturer’s suggested retail price of $599.95 (CAD 809.99). This refers to distance from the sensor surface to the subject. The distance from the front lens element to the subject is .47 in. (1.2cm). Using applicable CIPA Guideline measurement methods, when mounted on the FUJIFILM X-T4 mirrorless digital camera with Phase Detection AF activated and using High Performance Mode.
お知らせ • Sep 24FUJIFILM Holdings Corporation to Report Q2, 2023 Results on Nov 10, 2022FUJIFILM Holdings Corporation announced that they will report Q2, 2023 results on Nov 10, 2022
Upcoming Dividend • Sep 22Upcoming dividend of JP¥60.00 per shareEligible shareholders must have bought the stock before 29 September 2022. Payment date: 02 December 2022. Payout ratio is a comfortable 23% and the cash payout ratio is 91%. Trailing yield: 1.8%. Lower than top quartile of Mexican dividend payers (6.3%). Higher than average of industry peers (1.1%).
Reported Earnings • Aug 11First quarter 2023 earnings released: EPS: JP¥103 (vs JP¥143 in 1Q 2022)First quarter 2023 results: EPS: JP¥103 (down from JP¥143 in 1Q 2022). Revenue: JP¥625.9b (up 7.4% from 1Q 2022). Net income: JP¥41.4b (down 28% from 1Q 2022). Profit margin: 6.6% (down from 9.8% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 3.9%, compared to a 5.2% growth forecast for the industry in Mexico.
Board Change • Jul 18Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 independent directors. 7 non-independent directors. Independent Outside Director Tsuyoshi Nagano was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
お知らせ • Jul 07Fujifilm Launches Fujifilm Projector Z6000FUJIFILM Corporation announces it will launch “FUJIFILM PROJECTOR Z6000” in late July 2022. The new model joins the lineup of the Z Series of ultra-short-throw projectors, equipped with the industry’s only1 “folded two-axial rotatable lens.” FP-Z6000 offers a bright 6,000 lumens image projection capability and class-leading2 compact (460mm x 510mm x 162.5mm3) and lightweight design. By simply rotating “folded two-axial rotatable lens,” it is able to throw images at various directions. FP-Z6000 is also free from space constraints to accommodate highly immersive spatial designs, due to its ability to project large images from a close-up distance and to reposition them within an extensive vertical and horizontal range. In recent years, applications for projectors have been increasingly expanding into spatial design at commercial facilities, museums, and art galleries. Fujifilm entered into the projector market with the launch of the Z Series of projectors equipped with the world’s first “folded two-axial rotatable lens” in 2019. The “FUJIFILM PROJECTOR Z8000” (FP-Z8000) that the company subsequently introduced in 2021 provides bright image projection and excellent color reproduction. Users can place FP-Z8000 in inconspicuous places, drawing on the ability of the “folded two-axial rotatable lens” to project images toward various directions as well as the ability to throw massive images from a close-up distance. Since FP-Z8000 is capable of creating immersive spaces without blocking the beholders’ line of sight, its adoption in museums or immersive digital art exhibitions has been spreading. With the launch of FP-Z6000, Fujifilm adds a high-brightness model to the Z Series lineup. The company aims to expand the attraction of the series by further increasing the customers’ options. Featuring a “folded two-axial rotatable lens” for spatial presentation as intended by designer “Folded two-axial rotatable lens” can be tilted 90 degrees from the lens mount axis and rotated 360 degrees on the lens axis. The ability to throw images in various directions allows users to project images onto not only walls and screens but also ceilings and floors with ease. It can also create immersive space by hiding the main unit and exposing only lens section. Projecting massive 100-inch images from a close-up distance of 72cm The ultra-short throw lens with the TR value of 0.34 projects dynamic 100-inch images from a close-up distance of 72cm. This significantly reduces dead space between the projector and the projection surface, allowing maximum use of space. Class-leading2Wide Lens-Shift Range4 capable of 70% vertically and 35% horizontally. The use of a large-diameter aspherical lens element delivers the class-leading Lens-Shift function of up to 70% vertically and 35% horizontally. The function makes it easy to shift the position of projected images across a wide range without having to change the location of the main unit or direction of the lens. Furthermore, its 1.1x optical zoom capability means the size of projected images can be adjusted easily. This optical zoom capability can be combined with the Lens Shift function to enable efficient image adjustments. FP-Z6000 adopts the “Two-Group Focusing Mechanism,” with which the projector can independently adjust the focus of the central and peripheral parts of an image. Even when users shift the position of projected images with the Lens-Shift function, the Two-Group Focusing Mechanism allows for the projector to adjust its focal placement and offer images focused from their center to periphery.
お知らせ • Jun 22FUJIFILM Holdings Corporation to Report Q1, 2023 Results on Aug 10, 2022FUJIFILM Holdings Corporation announced that they will report Q1, 2023 results on Aug 10, 2022
お知らせ • Jun 09FUJIFILM Holdings Corporation (TSE:4901) agreed to acquire Unigraphica Aktiengesellschaft.FUJIFILM Holdings Corporation (TSE:4901) agreed to acquire Unigraphica Aktiengesellschaft on June 8, 2022. The company will become a wholly owned subsidiary of Fujifilm and will be named FUJIFILM UNIGRAPHICA AG from July 1st, following the closure of the deal which is expected to take place later this month.
お知らせ • Jun 01FUJIFILM Corporation Begins U.S. Clinical Phase 2a Study of FF-10832 in Combination with KEYTRUDA for Patients with Advanced Solid TumorsFUJIFILM Corporation announced that it has begun implementation of a phase 2a study in the U.S. to evaluate safety, tolerability, and preliminary efficacy of FF-10832, a liposomal drug candidate, in combination therapy with Merck & Co. Inc., Rahway, N.J., U.S.A.’s anti-PD-1 therapy KEYTRUDA® (pembrolizumab) for patients with advanced solid tumors. FF-10832 is a liposomal formulation which encapsulates gemcitabine, an approved anti-cancer agent indicated for the treatment of a variety of solid tumors. The primary focus of the trial is to establish the safety and tolerability of FF-10832 in combination with KEYTRUDA in patients with advanced solid tumors, and evaluate its preliminary efficacy in non-small cell lung cancer (NSCLC) and urothelial cancer (UC) patients who have progressed after standard therapy, including immune checkpoint inhibitor therapy. This trial will enroll up to 100 patients in two indications (UC and NSCLC) into one of two treatment arms (monotherapy or in combination with KEYTRUDA). Fujifilm has completed the phase 1 dose escalation of FF-10832 monotherapy, and is currently conducting an expansion phase. FF-10832 is administered as an intravenous infusion. It consists of liposomes, artificially constructed lipid vesicles that resemble biological membranes in composition and physical properties, encapsulating gemcitabine. Encapsulating a therapeutic agent in liposomes is believed to enhance pharmacological efficacy of that agent by prolonging its circulation and improving delivery of it specifically at the tumor site. An exploratory endpoint of the clinical phase 2a study is to determine whether encapsulating gemcitabine in liposomes enhances pharmacological efficacy. Preclinical studies have demonstrated that the combination of FF-10832 and immune checkpoint inhibitors impact CD8-positive T cells and may lead to longer survival compared to monotherapy. KEYTRUDA is an anti-PD-1 immune checkpoint inhibitor therapy.
Board Change • May 31Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 7 non-independent directors. Independent Outside Director Makiko Eda was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.